Greater Cannabis Company Inc
OTC:GCAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Greater Cannabis Company Inc
Cash from Financing Activities
Greater Cannabis Company Inc
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Greater Cannabis Company Inc
OTC:GCAN
|
Cash from Financing Activities
$3.6k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-62%
|
CAGR 10-Years
N/A
|
|
|
Uber Technologies Inc
NYSE:UBER
|
Cash from Financing Activities
-$5.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S&P Global Inc
NYSE:SPGI
|
Cash from Financing Activities
-$4.9B
|
CAGR 3-Years
24%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Alphabet Inc
NASDAQ:GOOGL
|
Cash from Financing Activities
-$37.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-24%
|
|
|
Netflix Inc
NASDAQ:NFLX
|
Cash from Financing Activities
-$7.5B
|
CAGR 3-Years
-178%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Meta Platforms Inc
NASDAQ:META
|
Cash from Financing Activities
-$20.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-65%
|
|
Greater Cannabis Company Inc
Glance View
The Greater Cannabis Co., Inc. focuses on the commercialization of licensed technology for medical medicinal or recreational cannabis. The company is headquartered in Baltimore, Maryland. The company went IPO on 2018-07-09. The Company’s product is an oral transmucosal patch platform, which provides for loaded actives to be absorbed by the buccal mucosa into the body. The firm is also pursuing in the cannabidiol (CBD) space, including in cosmetic, beauty, and health and wellness products business. The firm seeks to license cannabinoid therapeutic technologies from medical and academic institutions.
See Also
What is Greater Cannabis Company Inc's Cash from Financing Activities?
Cash from Financing Activities
3.6k
USD
Based on the financial report for Dec 31, 2025, Greater Cannabis Company Inc's Cash from Financing Activities amounts to 3.6k USD.
What is Greater Cannabis Company Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-62%
